Leukocyte activation in atherosclerosis: Correlation with risk factors

Atherosclerosis

Volumn 131, Issue 1, 1997, Pages 79-84

  Elneihoum, A M ^a   Falke, P ^a   Hedblad, B ^a   Lindgarde F ^a   Ohlsson, K ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Atherosclerosis; Cytokines; Leukocytes

Indexed keywords

CYTOKINE; LIPOCALIN; PROTEINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD LEVEL; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; INFLAMMATION; LEUKOCYTE ACTIVATION; LEUKOCYTE FUNCTION; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ACUTE-PHASE PROTEINS; AGED; ARTERIOSCLEROSIS; CAROTID ARTERIES; CARRIER PROTEINS; CHOLESTEROL; ENDOPEPTIDASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; REGRESSION ANALYSIS; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030910574     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)06077-7     Document Type: Article

References (38)

1. Jang IK, Lassila R, Fuster V. Atherogenesis and inflammation. Eur Heart J 1993;14(suppl K):2.
2. Russel R. The pathogenesis of atherosclerosis - an update. N Engl J Med 1986;314:488.
3. Belch JJF. The relationship between white blood cells and arterial disease. Curr Opin Lipidol 1994;5:440.
4. Fisher TC, Meiselmann HJ. Polymorphonuclear leukocytes in ischemic vascular disease. Thromb Res 1994;74(Suppl 1):S21.
5. Kochanek PM, Hallenbeck JM. Polmymorphonuclear leukocytes and monocytes/ macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 1992;23:1367.
6. Harlan JM. Neutrophil mediated vascular injury. Acta Med Scand 1986;715(suppl):123
7. Aggarwal BB, Kohr WJ, Hass P E, Moffat B, Spencer SA, Henzel WJ, Bringman TS, Nedwin GE, Goeddel DV, Harkins RN. Human tumor necrosis factor. Production, purification and characterization. J Biol Chem 1985;260:2345.
8. Peetre C, Thysell H, Grubb A, Olsson I. A tumor necrosis factor binding protein is present in human biological fluids. Eur J Haematol 1988;41:414.
9. Diez-Ruiz A, Tilz GP, Zangerle R, Baier-Bitterlich G, Wachter H, Fuchs D. Soluble receptors for tumor necrosis factor in clinical laboratory diagnosis. Eur J Haematol 1995;54:1.
10. Ohlsson K, Linder C, Rosengren M. Monoclonal antibodies specific for neutrophil proteinase 4 production and use for isolation of the enzyme. Biol Chem Hoppe Seyler 1990;371:549.
11. Lundberg E, Bergenfeldt M, Ohlsson K. Release of immunoreactive human neutrophil proteinase 4, normally and in peritonitis. Scand J Clin Lab Invest 1991;51:23.
12. Kjeldsen L, Johnsen AH, Sengeløv H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatenase. J Biol Chem 1993;268:10425.
13. Axelsson L, Bergenfeldt M, Ohlsson K. Studies of the release and turnover of a human lipocalin. Scand J Clin Lab Invest 1995;55:577.
14. Berglund G, Elmståhl S, Janzon L, Larsson SA. The Malmö Diet and Cancer Study. Design and feasability. J Intern Med 1993;233:45.
15. Wendelhag I, Gustavsson T, Suurküla M, Berglund G, Wikstrand J. Ultrasound measurment of wall thickness in the carotid artery. Fundamental principles and description of a computerized analysing system. Clin Phys 1991;11:565.
16. Persson J, Stavenow L, Wikstrand J, Israelsson B, Formgren J, Berglund G. Non-invasive quantification of atherosclerotic lesions. Reproducibility of ultrasonographic measurments of arterial wall thickness and plaque size. Arterioscler Thromb 1993;13:482.
17. Ohlsson K, Linder C, Lundberg E, Axelsson L. Release of cytokines and proteases from human peripheral blood mononuclear and polymorphonuclear cells following phagocytosis and LPS stimulation. Scand J Clin Lab Invest 1996;56:461.
18. Elneihoum AM, Falke P, Axelsson L, Lundberg F, Lindgärde F, Ohlsson K. Leukocyte activation detected by increased plasma inflammatory mediators in patients with ischaemic cerebrovascular disease. Stroke 1996;27:1734.
19. Vaddi K, Nicolini FA, Mehta P, Mehta JL. Increased secretion of tumor necrosis factor-alpha and interferon gamma by mononuclear leukoctys in patients with ischemic heart disease. Relevance in superoxide anion generation. Circulation 1994;90:694.
20. Basaran Y, Basaran MM, Babacan KF, Ener B, Okay T, Gök H, Özdemir M. Serum tumor necrosis factor levels in acute myocardial infarction and unstable angina pectoris. Angiology 1993;44(4):332.
21. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301.
22. Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Cotran RS, Gimbrone MA, JR. Recombinant tumor necrosis factor induce procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin-1. Proc Natl Acad Sci USA 1986;83:4533.
23. Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA, JR. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 1984;160:618.
24. van Deventer SJH, Büller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic and complement pathways. Blood 1990;76:2520.
25. Riancho JA, Zarrabeitia MT, Amado JA, Olmos JM, Gonzales-Macias J. Age-related differences in cytokine secretion. Gerontology 1994;40:8.
26. Mügge A, Lopez JAG. Do leukocytes have a role in hypertension? Hypertension 1991;17:331.
27. Schmid-Schönbein GW, Seiffge D, Delano FA, Shen K, Zweifach BW. Leukocyte count and activation in spontenously hypertensive and normotensive rats. Hypertension 1991;17:323.
28. Dalekos GN, Elisaf MS, Papagalanis N, Tzallas C, Siamopoulos KC. Elevated interleukin-1β in the circulation of patients with essential hypertension befors any drug therapy: a pilot study. Eur J Clin Invest 1996;26:936.
29. Lipowsky HH, Usami S, Chen S. In vivo measurement of apparent viscosity and microvessel hematocrit in the mesenteric artery of the cat. Microvasc Res 1980;19:297.
30. Katusic ZC, Vanhoutte PM. Superoxide anion is an endothelium-derived contracting factor. Am J Physiol 1989;257:H33.
31. Ohlstein EH, Nichols AJ. Rabbit polymorphonuclear neutrophils elicit endothelium-dependent contraction in vascular smooth muscle. Circ Res 1989;65:917.
32. Dzau VJ, Gonzalez D, Kaempfer C, Dubin D, Wintroub DU. Human neutrophils release serine proteases capable of activating prorenin. Circ Res 1987;60:595.
33. Wintroub BU, Klickstein LB, Dzau VJ, Watt KW. Granulocyte-angiotensin system: identification of angiotensinogen as the plasma protein substrate of leukocyte cathepsin G. Biochemistry 1984;23:227.
34. Zalokar JB, Richard JL, Claude, JR. Leukocyte count, smoking and myocardial infarction. N Engl J Med 1981;304:465.
35. Petitti DB, Kipp H. The leukocyte count: association with intensity of smoking and persistence of effect after quitting. Am J Epidmiol 1986;123:89.
36. Tappia PS, Troughton KL, Langley ESC, Grimble RF. Cigarette smoking influences cytokine production and antioxidant defences. Clin Sci Colch 1995;88:485.
37. Dovgan PS, Edwards JD, Zhan X, Wilde M, Agrawal DK. Cigarette smoking increase monocyte adherence to cultured endothelial cell monolyer. Biochem Biophys Res Commun 1994;203:929.
38. De Servi S, Mazzone A, Ricevuti G, Mazzucchelli I, Fossati G, Gritti D, Angoli L, Specchia G. Clinical and angiographic correlates of leukocyte activation in unstable angina. J Am Coll Cardiol 1995;26:1146.